MedTrace Logo

Caudal Dexamethasone - Bupivacaine in Neonates

NCT07609836 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-05-27

No results posted yet for this study

Summary

Randomied controlled study Evaluate the effects of caudal Dexamethasone in neonates

Conditions

  • We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

Interventions

PROCEDURE

We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonsates undergoing inguinal hernia repair in Dexamethasone - Bupivacaine group

We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonates undergoing inguinal hernia repair

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07609836 on ClinicalTrials.gov